Sema4, spun out of Icahn School of Medicine, has achieved a valuation of more than $1bn following a $121m series C round.
Sema4, a US-based health information spinout from integrated health system Mount Sinai Health System, yesterday raised $121m in a series C round led by investment management company BlackRock.
Deerfield Management Company, Moore Strategic Ventures, Blackstone, Section 32, Oak HC/FT, Decheng Capital and Connecticut Innovations also took part in the round, which valued Sema4 at more than $1bn post-money.
Sema4 provides screening services to help diagnose, treat and prevent disease. The company initially focused on producing models for reproductive…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).